This year marks a major milestone: 30 years since the founding of ecoNugenics by integrative medicine pioneer, Dr. Isaac Eliaz.

From the beginning, our mission has been clear—advance the field of integrative health through clinically researched, science-backed nutraceuticals that make a real difference.

Since 1995, our commitment to clinical innovation has remained unwavering. It began with the development of PectaSol, the original and only clinically researched Modified Citrus Pectin (MCP).

In 1999, we filed our first patent detailing its unique molecular structure—and the research momentum has only grown since:

• 2003: Our first clinical study showed PectaSol’s support for prostate cellular health and healthy PSA levels.*
  
  
• 2006: Published clinical research demonstrated PectaSol’s ability to safely remove heavy metals like lead, mercury, and arsenic.*
  
  
• 2008: Groundbreaking findings revealed PectaSol's inhibition of galectin-3, a protein now recognized as a central driver of today’s most critical health concerns.*
  
  
• 2010–2011: Peer-reviewed studies on ProstaCaid and BreastDefend added to our growing portfolio, highlighting benefits for prostate and breast cellular health.*
  
  
• 2011–2020: Third-party research accelerated, with over 50 independent studies validating PectaSol’s role as a natural galectin-3 inhibitor.*
  
  
• 2020: Launch of GlyphoDetox, a first-of-its-kind daily detox formula designed to support the body’s natural defenses against glyphosate and environmental toxins.*
  
  
• 2021: A landmark Phase 2 multi-center clinical trial confirmed PectaSol’s long-term benefits in nutritional support for prostate health and healthy PSA levels.*
  
  
• 2024: Expansion of the PectaSol line with PectaSol Berry, a naturally flavored powder, and introduction of PowerBiotic, a clinically researched spore-based probiotic for gut and immune health, and the launch of our 28-Day Detox Reset Program.*
  
  
• 2025: Launch of PectaPaws, bringing the researched benefits of PectaSol to the companion pet space.*
  
  
• 2025: Introduction of the new ecoNugenics Professional platform, a dedicated space for practitioner education, clinical tools, and implementation support—advancing our commitment to integrative health partnerships.

Thirty years later, we remain at the forefront of integrative health, guided by science and grounded in unparalleled results. With over 100 published peer-reviewed studies on PectaSol, our commitment to clinical rigor and real-world outcomes is unmatched. Click here to learn more about PectaSol Modified Citrus Pectin.

As we look ahead, our focus is clear: continue delivering the innovative, research-driven solutions that practitioners and health seekers can trust—for the next 30 years and beyond.

Sources:

Guess BW, Scholz MC, Strum SB, Lam RY, Johnson HJ, Jennrich RI. Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men…: a phase II pilot study. Prostate…Prostatic Dis. 2003;6(4):301-4.

Eliaz I, Hotchkiss AT, Fishman ML, Rode D. The effect of modified citrus pectin on urinary excretion of toxic elements. Phytother Res. 2006 Oct;20(10):859-64.

Huang ZL, Liu HY. [Expression of galectin-3 in liver…and the inhibitory effect of modified citrus pectin]. Nan Fang Yi Ke Da Xue Xue Bao. 2008 Aug;28(8):1358-61

Yan J, Katz AE. ProstaCaid induces G2/M cell cycle…Integr..Ther. 2010 Jun;9(2):186-96.

Jiang J, Wojnowski R, Jedinak A, Sliva D. Suppression of…by dietary supplement BreastDefend. Integr…Ther. 2011 Jun;10(2):192-200.

Keizman D, Frenkel M, Peer A, Kushnir I, Rosenbaum E, Sarid D, Leibovitch I, Mano R, Yossepowitch O, Margel D, Wolf I, Geva R, Dresler H, Rouvinov K, Rapoport N, Eliaz I. 24. Modified Citrus Pectin…Results of a Prospective Phase II Study.Nutrients. 2021; 13(12):4295.